Infect Chemother.  2013 Jun;45(2):241-243. 10.3947/ic.2013.45.2.241.

Innocent Neonate, Resistant Staph, and Embarrassed Staff

• Jo DS

• KMID: 2285008
• DOI: http://doi.org/10.3947/ic.2013.45.2.241

Abstract

No abstract available.

MeSH Terms

Humans
Infant, Newborn

Reference

1. Healy CM, Hulten KG, Palazzi DL, Campbell JR, Baker CJ. Emergence of new strains of methicillin-resistant Staphylococcus aureus in a neonatal intensive care unit. Clin Infect Dis. 2004. 39:1460–1466.

2. Jevons MP. "Celbenin" resistant staphylococci. BMJ. 1961. 1:124–125.

3. Ito T, Katayama Y, Asada K, Mori N, Tsutsumimoto K, Tiensasitorn C, Hiramatsu K. Structural comparison of three types of staphylococcal cassette chromosome mec integrated in the chromosome in methicillin-resistant Staphylococcus aureus. Antimicrob Agents Chemother. 2001. 45:1323–1336.

4. Storch GA, Rajagopalan L. Methicillin-resistant Staphylococcus aureus bacteremia in children. Pediatr Infect Dis. 1986. 5:59–67.

5. Bertini G, Nicoletti P, Scopetti F, Manoocher P, Dani C, Orefici G. Staphylococcus aureus epidemic in a neonatal nursery: a strategy of infection control. Eur J Pediatr. 2006. 165:530–535.

6. Köser CU, Holden MT, Ellington MJ, Cartwright EJ, Brown NM, Ogilvy-Stuart AL, Hsu LY, Chewapreecha C, Croucher NJ, Harris SR, Sanders M, Enright MC, Dougan G, Bentley SD, Parkhill J, Fraser LJ, Betley JR, Schulz-Trieglaff OB, Smith GP, Peacock SJ. Rapid whole-genome sequencing for investigation of a neonatal MRSA outbreak. N Engl J Med. 2012. 366:2267–2275.

7. Kim YB, Moon JY, Park JH. Associated-genes and virulence factors of Staphylococcus aureus isolated from nasal cavity of neonates. J Korean Pediatr Soc. 2003. 46:24–32.

8. Stein GE, Craig WA. Tigecycline: a critical analysis. Clin Infect Dis. 2006. 43:518–524.

9. Centers for Disease Control and Prevention (CDC). Staphylococcus aureus resistant to vancomycin–United States, 2002. MMWR Morb Mortal Wkly Rep. 2002. 51:565–567.

10. Infectious Diseases Society of America. The 10 x '20 Initiative: pursuing a global commitment to develop 10 new an-tibacterial drugs by 2020. Clin Infect Dis. 2010. 50:1081–1083.